Correspondence 0001493152-24-026942 from CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC.
Date: July 11, 2024 · CIK: 0001851484 · Accession: 0001493152-24-026942
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275506
Letter
VIA EDGAR
July 11, 2024
TenX Keane Acquisition
420 Lexington Ave.
Suite
New York, NY 10170
(347) 627-0058
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Re: TenX Keane Acquisition
Amendment No. 5 to Registration Statement on Form S-4
Filed July 11, 2024
File No. 333-275506
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), TenX Keane Acquisition (the “Registrant”) hereby requests that the effectiveness of the Registration Statement on Form S-4 (File No. 333-275506) filed by the Registrant on November 13, 2023, as amended by Amendment No. 1 filed on January 30, 2024, Amendment No. 2 filed on May 3, 2024, Amendment No. 3 filed on June 17, 2024, Amendment No. 4 filed on July 11, 2024, and Amendment No. 5 filed on July 11, 2024 (the “Registration Statement”), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to 4:30 p.m., Eastern time, on July 12, 2024, or as soon as reasonably practicable thereafter.
If you have any questions, please feel free to contact Eric Mendelson (emendelson@cronelawgroup.com / telephone: (917) 538-1775) of The Crone Law Group, P.C. In addition, please notify Mr. Mendelson when this request for acceleration has been granted.
Very
truly yours,
TenX
Keane Acquisition
Show Raw Text
CORRESP
1
filename1.htm
VIA
EDGAR
July
11, 2024
TenX
Keane Acquisition
420 Lexington Ave.
Suite
2446
New
York, NY 10170
(347) 627-0058
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
Washington,
D.C. 20549
Re:
TenX
Keane Acquisition
Amendment
No. 5 to Registration Statement on Form S-4
Filed
July 11, 2024
File
No. 333-275506
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), TenX Keane Acquisition
(the “Registrant”) hereby requests that the effectiveness of the Registration Statement on Form S-4 (File No. 333-275506)
filed by the Registrant on November 13, 2023, as amended by Amendment No. 1 filed on January 30, 2024, Amendment No. 2 filed on May 3,
2024, Amendment No. 3 filed on June 17, 2024, Amendment No. 4 filed on July 11, 2024, and Amendment No. 5 filed on July 11, 2024 (the
“Registration Statement”), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”)
to 4:30 p.m., Eastern time, on July 12, 2024, or as soon as reasonably practicable thereafter.
If
you have any questions, please feel free to contact Eric Mendelson (emendelson@cronelawgroup.com / telephone: (917) 538-1775) of The
Crone Law Group, P.C. In addition, please notify Mr. Mendelson when this request for acceleration has been granted.
Very
truly yours,
TenX
Keane Acquisition
By:
/s/
Taylor Zhang
Title:
Chief
Financial Officer
cc:
Eric Mendelson
The Crone Law Group, P.C.